Increased EZH2 activity has been found in ~85% of epithelial ovarian carcinomas through genetic amplification and loss of antagonistic protein activity54, 55, 56, 57 and is functionally implicated in tumor development and proliferation.56, 58. This evidence concerns the gene EZH2 and neoplasm.